Inovio Pharmaceuticals (INO) Common Equity (2010 - 2026)
Inovio Pharmaceuticals (INO) recorded Common Equity of $4.37 million in Q2 2026, down 84.7% from $28.53 million a year earlier and down 28.0% from the prior quarter.
Powered by 
Analysis
Inovio Pharmaceuticals (INO) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, Inovio Pharmaceuticals reported Common Equity of $24.1 million, down 64.8% from FY2024.
- Annual Common Equity has declined for five straight years, with a five-year compound annual growth rate of -44.6% (FY2020 to FY2025).
- Across earlier years, Common Equity came in at $68.5 million in FY2024 (-41.6%), $117.35 million in FY2023 (-47.2%), $222.36 million in FY2022 (-44.4%) and $399.67 million in FY2021 (-13.3%).
- Quarterly Common Equity has ranged from -$7.72 million in Q3 2025 to $453.57 million in Q3 2021 over the past five years.
- On a year-over-year basis, Common Equity has declined for three consecutive quarters, with an average decline of 63.2% over the last seven quarters.
- Peak year-over-year performance for Common Equity in the last five years was growth of 40.0% in Q3 2021, against a decline of 88.2% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $6.07 million (Q1 2026), $24.1 million (Q4 2025) and -$7.72 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Inovio Pharmaceuticals | 68.56 Mn | -115.11 Mn | - | 4.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.37 Mn |
| Mar 31, 2026 | 6.07 Mn |
| Dec 31, 2025 | 24.10 Mn |
| Sep 30, 2025 | -7.72 Mn |
| Jun 30, 2025 | 28.53 Mn |
| Mar 31, 2025 | 51.25 Mn |
| Dec 31, 2024 | 68.50 Mn |
| Sep 30, 2024 | 73.54 Mn |
| Jun 30, 2024 | 96.74 Mn |
| Mar 31, 2024 | 94.44 Mn |
| Dec 31, 2023 | 117.35 Mn |
| Sep 30, 2023 | 138.16 Mn |
| Jun 30, 2023 | 169.37 Mn |
| Mar 31, 2023 | 199.21 Mn |
| Dec 31, 2022 | 222.36 Mn |
| Sep 30, 2022 | 266.70 Mn |
| Jun 30, 2022 | 297.67 Mn |
| Mar 31, 2022 | 355.09 Mn |
| Dec 31, 2021 | 399.67 Mn |
| Sep 30, 2021 | 453.57 Mn |
API Access
Inovio Pharmaceuticals Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=INO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "INO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=INO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();